NUAK1 and neoplasm: Adopting in vitro and in vivo settings, we showed that knocking down NUAK1 promoted the cell migration ability of GC cell line, was correlated to a decrease in tumor growth and rise on ROS content, while miR-622 tended to counteract the activities of NUAK1.